Stock Price Quote

BALAXI PHARMACEUTICALS LTD.

NSE : BALAXIBSE : ISIN CODE : INE618N01014Industry : TradingHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE617.55-2.4 (-0.39 %)
PREV CLOSE( ) 619.95
OPEN PRICE ( ) 612.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 617.55 (314)
VOLUME 37465
TODAY'S LOW / HIGH( ) 612.00 669.80
52 WK LOW / HIGH ( )399.95 686.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-09 1942
Management Info
- Chairman Ashish Maheshwari - Managing Director
Registered Office

Address Plot No. 409, H. No. 8-2-293,Maps Towers, 3rd Floor, Phase I I I,Road No. 81, Jubilee Hills,
Hyderabad,
Telangana-500096

Phone 040 23555300

Email info@balaxi.in

Website www.balaxipharma.in

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : NSE, Chennai

NEWS

15Feb Muthoot Finance, HDFC Life Insurance a
Muthoot Finance’s board has approved additional equity infusion of Rs 30..
14Feb Balaxi Pharmaceuticals’ arm incorporat
Balaxi Pharmaceuticals’ wholly owned subsidiary -- Balaxi Global DMCC ha..
25Jan Allotment of Convertible warrants
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding allot..
10Jan General Announcement
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certifica..
27Dec Closure of Trading Window
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the T..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit4.87999999999999162.23
Gross Profit 7.65999999999999 224.52
Operating Profit 13.09234.26
Net Sales 1271081.38

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Macfos (BSE)
peergroup  506.30 (10.04%)
M.Cap ( in Cr)447.34
Sinnar Bidi Udyog (BSE)
peergroup  449.20 (4.99%)
M.Cap ( in Cr)17.97
Veritas (India) (BSE)
peergroup  777.25 (1.99%)
M.Cap ( in Cr)2083.81
India Motor Parts (BSE)
peergroup  1029.10 (1.21%)
M.Cap ( in Cr)1284.32
Manbro Industries (BSE)
peergroup  596.30 (1.99%)
M.Cap ( in Cr)29.88

Shareholding Pattern

PROMOTERS 71.22%
NON-INSTITUTION 10.18%
FI/BANKS/INSURANCE 0.03%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Balaxi Pharmaceuticals Ltd.

Balaxi Pharmaceuticals Ltd. was incorporated in the year 1942. Its today's share price is 0. Its current market capitalisation stands at Rs 663.7 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1081.38 Cr and Total Income of Rs.1147.42 Cr. The company's management includes Udayan Abhilash Shukla, Purnima Singh, Mangina Srinivas Rao, Gandhi Gamji, Kunal M Bhakta, Minoshi Maheshwari, Ashish Maheshwari.

It is listed on the BSE with a BSE Code of  , NSE with an NSE Symbol of BALAXI and ISIN of INE618N01014. It's Registered office is at Plot No. 409, H. No. 8-2-293,Maps Towers, 3rd Floor, Phase I I I,Road No. 81, Jubilee HillsHyderabad-500096, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Mohan & Ravi, P Murali & Co, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.